News

Philip Morris Cuts Guidance Amid Zyn Challenges

Business

Philip Morris Cuts Guidance Amid Zyn Challenges

7 sourcesUpdated Jul 22, 20261 min read

0

Sponsored

PMI is increasing investment in its Zyn nicotine pouches to maintain US leadership amid intensifying competition. In the June quarter, the company reported about $11.2 billion in revenue and surpassed earnings expectations, with adjusted earnings per share around $2.20. It rolled out Zyn Ultra and additional flavors, and plans 1.5 mg and 8 mg variants plus expanded marketing and distribution to defend market share. Despite the beat, PMI trimmed its full-year adjusted EPS guidance for a third time this year, citing adverse currency movements and higher input costs from global events. The firm faces pressure from rivals such as BAT’s Velo, but has benefited from FDA positioning that allows some Zyn products to be marketed as less harmful, supporting continued product diversification and pricing strategies. Overall, PMI’s results highlight strong momentum in its smoke-free portfolio while headwinds from currency and competition temper growth expectations.

Sponsored

In this story:British American TobaccoPhilip Morris International Inc.United States Food and Drug AdministrationVelocetteUnited States of America

Where do you stand?

British American Tobacco

Philip Morris International Inc.

United States Food and Drug Administration

More on this story

Back to News

Finance

Reported Short Interest Spikes Across Four OTC Stocks

October short interest rose sharply for AB Dynamics, Tullow Oil, Agentix and GoTo, although the reported increases started from exceptionally small mid-month totals. Shares were largely flat in the reports, and Tullow retained a consensus “Moderate Buy” rating.

637 sources

Finance

Short Interest Falls Over 93% Across Four FT Vest ETFs

Short interest in four FT Vest U.S. Equity Deep Buffer ETFs—May, February, November and April—fell roughly 93% to 94% in October, leaving short positions near zero and days-to-cover ratios below one. The reports also noted recent institutional trading in several of the funds.

120%

Center

360%

Right

120%

Other

2

Total sources7

Last updatedJul 22, 2026

Does this breakdown look right?

Sponsored

How it spread

Broke Bloomberg · Jul 22, 7:29 AM ETLeft within the hourRight +1hCenter +2h6 sources +4h on

Claim check

What each side asserts, disputes — or leaves out entirely.

Analyzing the coverage…

Where do you land?

Whose framing of this story rings truest to you?

Sponsored

How each side headlines it

Left· 1 source

“Philip Morris Trims Profit Forecast on Currencies, Rising Costs”

Bloomberg · Jul 22, 2026

Center· 3 sources

“Philip Morris Ramps Spending to Grow Zyn Brand -- Update”

MarketScreener · Jul 22, 2026

Right· 1 source

“Philip Morris cuts profit forecast again, ramps up investment in Zyn”

Fort Worth Star-Telegram · Jul 22, 2026

Coverage

Sponsored

Comments

Ask Genius by OpenServe:

Free account · your comment posts right after signup

Sponsored

655 sources

Sponsored

Business

Anthropic IPO Valuation Could Reach $1.5 Trillion

Anthropic’s planned IPO is facing mounting uncertainty as investors reportedly push to lower its expected valuation from roughly $1.4 trillion–$1.5 trillion, with estimates ranging toward $1 trillion to $1.3 trillion amid a sell-off in AI stocks. Prediction-market odds for a near-term listing have also fallen, and reports say the company could reduce the offering or delay it.

473 sources